SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: Maurice Winn who wrote (2678)10/25/1998 6:42:00 PM
From: Bob L  Read Replies (1) | Respond to of 3702
 
Ah, Maurice, but Bexxar does not work well in intermediate or high grade. This is clear from the phase I results, and the fact that every document Coulter puts out nowadays says Bexxar is for "low grade and transformed low grade". True, the radiation should kill the nasty cells, but the molecule just doesn't stick to the aggressive grades well.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News